about the symposium
Geared towards research trainees and fellows, this half-day research symposium offers a unique opportunity to delve into the latest advancements, trends, and challenges shaping the field of cellular therapy.
All trainees are encouraged to submit an abstract describing their original basic science or translational research in the field of cellular therapy. Several abstracts will be selected for oral presentation with others presented during the poster session.
event details
Date: September 19, 2024
Time: 12:00PM-5:00PM CST
Location: Knapp Center for Biomedical Discover (KCBD) Registration: Free (Limited spots available)
Who Should Attend
Research Trainees
Fellows
Postdoctoral Researchers
Graduate Students
Early-Career Scientists
why should you attend?
Cutting-Edge Insights: Gain valuable insights into the cutting-edge research driving cellular therapy forward.
Oral/Poster Presentations: Showcase your own research and receive constructive feedback from peers and experts.
Interactive Sessions: Engage in interactive sessions including Q&A with leading researchers and clinicians.
Networking Opportunities: Connect with peers, mentors, and experts in the field to foster collaborations and exchange ideas.
Career Development: Learn about career opportunities and paths in cellular therapy research, and gain valuable advice from experienced professionals.
registration
Registration for the Jonas Center Cellular
Therapy Satellite Symposium for Research
Trainees is now open. Secure your spot today to
be part of this dynamic event!
Abstract Guidelines and Submission
The deadline for abstract submission for the
Jonas Center Cellular Therapy Satellite
Symposium for Research Trainees is extended to
July 26, 2024.
agenda
Course Directors:
Nathan Singh, MD, MS (WashU)
Justin Kline, MD (Univ. of Chicago)
Agenda TBD
| Time | Agenda |
|---|---|
| 12:00 - 12:45PM | Lunch and Registration |
| 12:45 - 12:50PM | Welcome and Introductions Peter Riedell |
| 12:50 - 12:55PM | Oral Session 1 Faculty moderator: Nathan Singh |
| 12:55 - 1:10PM | Targeting PRDM1 to enhance CAR T Cell therapy against diffuse large B cell lymphoma (DLBCL) Sidney Wang |
| 1:10 - 1:25PM | Regulation of the transcriptional repressor BACH2 overcomes tonic signaling-driven CAR T cell dysfunction Tien-Ching Chang |
| 1:25 - 1:40PM | Inclusion of a c-MYC 5’-UTR sequence impacts the efficacy of second-generation CD19-directed CAR T cells Lishi Xie |
| 1:40 - 1:55PM | Proximity labeling to characterize the CAR interactome Deepesh Kumar Gupta |
| 1:55 - 2:15PM | BREAK |
| 2:15 - 2:20PM | Oral Session 2 Faculty moderator: Justin Kline |
| 2:20 - 2:35PM | Generation of MHC-independent T cell receptors using rational protein engineering Ju-Fang Chang |
| 2:35 - 2:50PM | Inhibition of PI3K/ signaling promotes an early memory state in CAR T cells and enhances their in vivo persistence and efficacy Alexandra Rojek |
| 2:50 - 3:05PM | Epitope-edited allogeneic CD2 CAR-T (UCART2edit) for T cell malignancies Jingyu (Jerry) Xiang |
| 3:05 - 3:25PM | BREAK |
| 3:25 - 3:30PM | Oral Session 3 Faculty moderator: Nathan Singh |
| 3:30 - 3:45PM | Novel Small Molecule VLA-4 Inhibitors Optimized for Extended Hematopoietic Stem and Progenitor Cell Mobilization Mike Rettig |
| 3:45 - 4:00PM | Mechanisms and impact of bystander killing by CAR T cells Joanna Chorazeczewski |
| 4:00 - 4:15PM | Memory Like NK Cells as a Promising Immunotherapy for Glioblastoma Elizabeth Juarez Diaz |
| 4:15 - 4:20PM | Concluding remarks Drs. Singh, Kline, Riedell |
| 4:20 - 5:00PM | Light hors d'oeuvre, crudité station, alcoholic and non-alcoholic beverages |
contact us
For inquiries or assistance with registration, please contact:
Leslie Brizendine
Email: Leslie@meetingachievements.com
Office: 219.465.1115